Login or sign up
For business
Average ratingGreat
4.0/ 5

Based on 9 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Maxivax

Generated with AI from 9 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Eric Goldman
Reviews 1

I recently used Maxivax for my vaccination needs, and I'm happy to say that I had a positive experience. The staff was courteous and professional, making me feel comfortable throughout the process. The website was easy to use, and the booking was hassle-free. I would definitely recommend Maxivax to others.

Melanie Mikulic
Reviews 1

I am extremely satisfied with the services provided by Maxivax. The staff was professional, polite, and efficient. They went above and beyond to ensure all my needs were met. The website was user-friendly and easy to navigate, making the booking process seamless. I would highly recommend Maxivax to anyone in need of their services.

Mike Buchkovsky
Reviews 1

I recently used the services provided by a company that focuses on vaccines. I was super impressed with their level of professionalism and the quality of service. The website was easy to use and booking an appointment was a breeze. I would highly recommend their services to anyone in need of vaccination.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Maxivax

MaxiVAX is a Swiss clinical-stage biotechnology company, currently performing a first-in-man (phase I) trial in various tumours with MVX-ONCO-1.

MaxiVAX’ mission is to develop alternative solutions to “established cancer therapies” that are more effective, are personalized and enable the patient to fight his own disease. MaxiVAX’ first treatment, MVX-ONCO-1 has been classified as an Advanced Therapeutic Product by the European Medicines Agency. The resulting approval procedure is different than that of a traditional drug and should generally allow a faster development until market approval with fewer and less extensive clinical trials.

Website
maxivax.ch
Categories
Biotechnology